As published in Speciality Chemicals Magazine

Over the past 20 years, private equity firm Edgewater Capital Partners has focused on investing in lower to middle-market businesses, particularly niche manufacturers of specialty chemicals, pharmaceutical ingredients, engineered components and advanced materials. During that time, we have always collaborated with our senior management teams on current issues, challenges and concerns.

Read more on page 77.